ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiologic methods"

  • Abstract Number: 895 • 2013 ACR/ARHP Annual Meeting

    The Relative Risk Of Aortic Aneurysm In Patients With Giant Cell Arteritis Compared With The General Population

    Joanna Robson1, Amit Kiran2, Joseph Maskell3, Andrew Hutchings4, Nigel K. Arden5, Bhaskar Dasgupta6, William Hamilton7, Akan Emin8, David Culliford3 and Raashid A. Luqmani2, 1Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, United Kingdom, 2Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, University of Oxford, Oxford, United Kingdom, 3Faculty of Medicine, University of Southampton, Southampton, United Kingdom, 4Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom, 5NDORMS; MRC Lifecourse Epidemiology Unit, Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom, 6Rheumatology, Southend University Hospital, Westcliff-on-sea, United Kingdom, 7Primary Care Diagnostics, University of Exeter Medical School, Exeter, United Kingdom, 8Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom

    Background/Purpose: To evaluate the risk of aortic aneurysm in patients with giant cell arteritis (GCA) when compared with age, gender and location matched controls from…
  • Abstract Number: 1751 • 2013 ACR/ARHP Annual Meeting

    Ethnicity-Related Differences In Behçet’s Disease In a French Multiethnic Country

    David Saadoun1, Mathieu Resche Rigon2, Bertrand Wechsler3, Du Le Thi Huong4, Jean-Charles Piette1 and Patrice Cacoub5, 1Groupe Hospitalier Pitié Salpétrière, Service de Médecine Interne, DHU i2B, Paris, France, 2Department of Internal Medicine and Laboratory I3 “Immunology, Immunopathology, Immunotherapy”, UMR CNRS 7211, INSERM U959, Groupe Hospitalier Pitié-Salpetrière, Université Pierre et Marie Curie, Paris 6, Paris, France, Paris, France, 3Department of Internal Medicine 2. Referal center for SLE/APS, CHU Pitié-Salpêtrière, Paris, France, 4Internal Medicine, Groupe Hospitalier Pitié-Salpétrière, Paris, France, 5Internal Medicine, Assistance Publique-Hôpitaux de Paris, Hopital Pitié-Salpétrière, Paris, France

    Background/Purpose: It has been suggested that Behçet’s disease (BD) varies in its phenotypic expression in different ethnies and in different countries indicating that both environmental…
  • Abstract Number: 804 • 2013 ACR/ARHP Annual Meeting

    Tumour Necrosis Factor Inhibitors and The Risk Of Acute Coronary Syndrome In Rheumatoid Arthritis – a National Cohort Study

    Lotta Ljung1,2, Johan Askling3, Solbritt M. Rantapää-Dahlqvist4, Lennart T.H. Jacobsson5 and The ARTIS Study Group6, 1Clinical epidemiology unit, Karolinska Institutet, Stockholm, Sweden, 2Department for Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden, 3Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 4Department for Public Health and Clinical Medicine/ Rheumatology, Umeå University, Umeå, Sweden, 5Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, 6Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: The high risk of ischemic heart disease (IHD) in patients with rheumatoid arthritis (RA) has been linked to inflammation and disease severity. Treatment with…
  • Abstract Number: 1756 • 2013 ACR/ARHP Annual Meeting

    Trends In Incidence and Mortality In Rheumatoid Arthritis and Systemic Autoimmune Rheumatic Diseases In Quebec, Canada: A Population-Based Study

    Sonia Jean1, Philippe Gamache2, Marie Hudson3, Louis Bessette4, Paul R. Fortin5, Gilles Boire6 and Sasha Bernatsky7, 1Chronic disease surveillence division, National Institute of public health of Quebec, Quebec, QC, Canada, 2Chronic disease surveillance division, National institute of public health of Quebec, Quebec, QC, Canada, 3Rheumatology, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada, 4Centre Hospitalier Universitaire de Québec, pavillon CHUL, Sainte-Foy, QC, Canada, 5Medicine, Centre de Recherche du Chu de Québec et Université Laval, Quebec City, QC, Canada, 6Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada, 7Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada

    Background/Purpose: Health administrative data (HAD) are a potentially efficient to conduct population-based research and are increasingly used to develop chronic disease surveillance indicators. Examining trends…
  • Abstract Number: 805 • 2013 ACR/ARHP Annual Meeting

    Good Response On Tumour Necrosis Factor Inhibitors Are Associated With a Decreased Risk Of Acute Coronary Syndromes In Patients With Rheumatoid Arthritis

    Lotta Ljung1,2, Lennart T.H. Jacobsson3, Solbritt M. Rantapää-Dahlqvist4, Johan Askling5 and The ARTIS Study Group6, 1Clinical epidemiology unit, Karolinska Institutet, Stockholm, Sweden, 2Department for Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden, 3Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, 4Department for Public Health and Clinical Medicine/ Rheumatology, Umeå University, Umeå, Sweden, 5Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 6Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Inflammatory activity, as well as traditional cardiovascular risk factors, have been suggested to underlie the increased risk of coronary disease in patients with rheumatoid…
  • Abstract Number: 1715 • 2013 ACR/ARHP Annual Meeting

    Detection Of Enthesitis In Children With Enthesitis-Related Arthritis: Dolorimeter Examination Compared To Ultrasonography

    Pamela F. Weiss1, Nancy Chauvin2, Andrew J. Klink3, Russell A. Localio4, Chris Feudtner5, Diego Jaramillo2, Robert A. Colbert6, David D. Sherry7 and Ron Keren3, 1Rheumatology, The Children's Hospital of Philadelphia, Philadelphia, PA, 2Radiology, Children's Hospital of Philadelphia, PHILADELPHIA, PA, 3Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, 4Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 5Division of General Pediatrics, Children's Hospital of Philadelphia; University of Pennsylvania Center for Clinical Epidemiology and Biostatistics, Philadelphia, PA, 6NIAMS/NIH, Bethesda, MD, 7Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: To evaluate the distribution of enthesitis and accuracy of physical examination (PE) for the detection of enthesitis in children, using ultrasound with power Doppler…
  • Abstract Number: 782 • 2013 ACR/ARHP Annual Meeting

    Rates Of Malignancies In Patients From 5 Rheumatoid Arthritis Registries Across The World

    Johan Askling1, Niklas Berglind2, Stefan Franzén2, Thomas Frisell3, Christopher Garwood4, Jeffrey D. Greenberg5, Meilien Ho6, Marie Holmqvist1, Laura Horne7, Kathy Lampl8, Kaleb Michaud9, Fredrik Nyberg10, Dimitrios A. Pappas11, George Reed12, Eiichi Tanaka13, Trung Tran14, Suzanne Verstappen4, Hisashi Yamanaka15 and Deborah Symmons4, 1Karolinska Institutet, Stockholm, Sweden, 2AstraZeneca R&D Mölndal, Mölndal, Sweden, 3Clinical Epidemiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 4Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, 5Division of Rheumatology, Department of Medicine, NYU Hospital for Joint Diseases, New York, NY, 6AstraZeneca R&D Alderley Park, Macclesfield, United Kingdom, 7AstraZeneca, Wilmington, DE, 8AstraZeneca R&D Wilmington, Wilmington, DE, 9University of Nebraska Medical Center and National Data Bank, Omaha, NE, 10AstraZeneca R&D, Mölndal, Sweden, 11Columbia University, New York, NY, 12University of Massachusetts Medical School, Worcester, MA, 13Tokyo Women's Medical University, Tokyo, Japan, 14MedImmune LLC, Gaithersburg, MD, 15Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan

    Background/Purpose: The overall incidence of cancer in patients with rheumatoid arthritis (RA) is modestly elevated compared with the general population. The extent to which cancer…
  • Abstract Number: 1351 • 2013 ACR/ARHP Annual Meeting

    A Comparison Of The Clinical Effectiveness Of Treatment Strategies For Active RA Patients : Using a Prospective Biologic Registry (BIOPSY) and an RA Specific Cohort (KORONA)

    Yoon-Kyoung Sung1,2, Soo-Kyung Cho1,2, Chan-Bum Choi3,4, Soyoung Won5, So-Young Bang6, Hoon-Suk Cha7, Jung-Yoon Choe8, Won Tae Chung9, Seung-Jae Hong10, Jae-Bum Jun4, Hyoun Ah Kim11, Jinseok Kim12, Seong-Kyu Kim8, Tae-Hwan Kim4, Hye-Soon Lee13, Jaejoon Lee7, Jisoo Lee14, Shin-Seok Lee15, Sung Won Lee16, Yeon-Ah Lee10, Seong-Su Nah17, Chang-Hee Suh18, Dae-Hyun Yoo4, Bo Young Yoon19 and Sang-Cheol Bae1,2, 1Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 2Department of Rheumatology, Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, 3Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, 4Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 5Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, 6Hanyang University Guri Hospital, Guri, South Korea, 7Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 8Catholic University of Daegu School of Medicine, Daegu, South Korea, 9Division of Rheumatology, Department of Internal Medicine, Dong-A University Hospital, Busan, South Korea, 10Division of Rheumatology, Department of Internal Medicine, Kyung Hee University, Seoul, South Korea, 11Ajou University Hospital, Suwon, South Korea, 12Division of Rheumatology, Internal Medicine, Jeju National University Hospital, Jeju, Korea, South Korea, 13Department of Rheumatology, Hanyang University Guri Hospital, Guri, South Korea, 14Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, South Korea, 15Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea, 16Rheumatology, Dong-A University Hospital, Busan, South Korea, 17Division of Rheumatology, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, South Korea, 18Department of Rheumatology, Ajou University Hospital, Suwon, South Korea, 19Inje University Ilsan Paik Hospital, Goyang, South Korea

    Background/Purpose: The results from RCTs may not be generalizable to clinical practice because of their inclusion and exclusion criteria. Instead, observational cohorts and registries might…
  • Abstract Number: 303 • 2013 ACR/ARHP Annual Meeting

    Risk Of Cardiovascular Events In Patients With Psoriatic Arthritis, Psoriasis, and Rheumatoid Arthritis: A General Population-Based Cohort Study

    Alexis Ogdie1, Yiding Yu2, Kevin Haynes3, Samantha Maliha4, Thorvardur Love5,6, Andrea Troxel7, Sean Hennessy8, David Margolis9, Stephen Kimmel10, Nehal N. Mehta11, Hyon Choi12,13 and Joel Gelfand14, 1Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA, 2Medicine, Brigham and Women's Hospital, Boston, MA, 3Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 4University of Pennsylvania, Philadelphia, PA, 5Faculty of Medicine, University of Iceland, Reykjavik, Iceland, 6Landspitali University Hospital, Reykjavik, Iceland, 7Biostatistics and Epidemiology, University of Pennsylvania., Philadelphia, PA, 8Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, 9Dermatology and Epidemiology, University of Pennsylvania, Philadelphia, PA, 10Cardiology and Epidemiology, University of Pennsylvania, Philadelphia, PA, 11National Heart Lung Blood Institute, Cardiovascular and Pulmonary Division, NHLBI, National Institutes of Health, Bethesda, MD, 12Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 13Division of Rheumatology, Allergy, and Immunology Massachusetts General Hospital, Harvard Medical School, Boston, MA, 14Dermatology and Epidemiology, University of Pennsylvania., Philadelphia, PA

    Risk of Cardiovascular Events in Patients with Psoriatic Arthritis, Psoriasis, and Rheumatoid Arthritis: A general population-based cohort studyBackground/Purpose: Psoriatic arthritis (PsA), psoriasis, and rheumatoid arthritis…
  • Abstract Number: 1271 • 2013 ACR/ARHP Annual Meeting

    Longitudinal Disease Trajectory Of Juvenile Dermatomyositis

    Lily Siok Hoon Lim1,2, Eleanor Pullenayegum3, Dafna D. Gladman4, Earl D. Silverman5 and Brian M. Feldman6, 1Pediatric Rheumatology, Hospital for Sick Children, Toronto, ON, Canada, 2Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, ON, Canada, 3Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada, 4Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 5Rheumatology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 6Rheumatology, Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: 1) To determine the longitudinal disease activity trajectory of an inception cohort of Juvenile Dermatomyositis (JDM) patients, 2) To identify predictor(s) for longitudinal disease…
  • Abstract Number: 261 • 2013 ACR/ARHP Annual Meeting

    Concordance Of Hip Pain With Radiographic Hip Osteoarthritis In An Urban US Community: The Framingham Osteoarthritis Study

    Kyu Chan Kim1, David T. Felson2, Katherine D. Linsenmeyer3, Ali Guermazi4, Steven C. Vlad5, Mary M. Clancy6 and Jingbo Niu7, 1Internal Medicine and Rheumatology, Boston Medical Center, Boston, MA, 2Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 3Internal Medicine, Boston Medical Center, Boston, MA, 4Boston University, Boston, MA, 5Clinical Epidemiology, Boston University, Boston, MA, 6School of Medicine, Boston University, Boston, MA, 7Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: While it is well known that knee pain and radiographic knee osteoarthritis (OA) are often discordant, little is known of the concordance of hip…
  • Abstract Number: 1235 • 2013 ACR/ARHP Annual Meeting

    Predictors Of Fracture In Patients With Osteopenia: Data From An Observational Cohort

    Kathryn Mitchell1, Peter Diggle1 and Marwan Bukhari1,2, 1Faculty of Health and Medicine, Lancaster, United Kingdom, 2Department of Rheumatology, Royal Lancaster Infirmary, Lancaster, United Kingdom

    Background/Purpose: The risk factors for osteoporotic fragility fractures are well documented in the literature and although they are associated with a diagnosis of established osteoporosis…
  • Abstract Number: 262 • 2013 ACR/ARHP Annual Meeting

    Is There a Role For Non-Mendelian Inheritance In Severe Osteoarthritis Of The Knee

    Allen D. Sawitzke1, Richard Pimentel2, Jathine Wong2, Helena Martinez3, Marta Herrero3, Josep Verges4 and Daniel O. Clegg5, 1Rheumatology, University of Utah, Salt Lake City, UT, 2University of Utah, Salt Lake, UT, 3Pharmascience Division, Bioiberica S.A., Barcelona, Spain, 4Pharmacological Research Unit, Scientific Medical Department, Bioibérica, S.A., Barcelona, Spain, 5Rheumatology, George Wahlen VA Medical Center/University of Utah, Salt Lake City, UT

    Background/Purpose: Although the etiopathogenesis of osteoarthritis of the knee remains largely unknown, it is clear that genetic risks are contributory. Traditional family, twin, case control…
  • Abstract Number: 137 • 2013 ACR/ARHP Annual Meeting

    A Population-Based Survey and Physician Assessment Of The Characteristics and Prevalence Of Fibromyalgia

    Edgar H. Adams1, Shoshana Daniel2, Arthi B. Chandran3, Heather McElroy4, Caroline Schaefer1, Rachael Mann5, Gergana Zlateva3, Joseph C. Cappelleri6, Elizabeth T. Masters7, Annlouise R. Assaf6, Michael McNett8, Stuart L. Silverman9, Roland Staud10 and Philip Mease11, 1Covance Market Access Services Inc., Gaithersburg, MD, 2Covance Market Access Services Inc., Conshohocken, PA, 3Pfizer Inc., New York, NY, 4Covance Market Access Services, Sydney, Australia, 5Covance Market Access Services Inc., San Diego, CA, 6Pfizer Inc., Groton, CT, 7Pfizer Inc, New York, NY, 8Aurora Pain Program, Milwaukee, WI, 9Cedars-Sinai Medical Center, UCLA Center of Excellence, Los Angeles, CA, 10Dept Med/Rheum/Clin Immun Div, University of Florida, Gainesville, FL, 11Director, Rheumatology Research, Swedish Medical Center, Seattle, WA

    Background/Purpose: No large-scale, national study estimating fibromyalgia (FM) prevalence in the United States (US) has been conducted involving physician evaluation.  The study objective was to…
  • Abstract Number: 1220 • 2013 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis Characteristics and Fracture Risk: A Population-Based Study

    Shreyasee Amin1, Sherine E. Gabriel2, Sara J. Achenbach3, Elizabeth J. Atkinson3, Terry M. Therneau3 and L. Joseph Melton III3, 1Division of Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN, 3Department of Health Sciences Research, Mayo Clinic, Rochester, MN

    Background/Purpose: Women and men with rheumatoid arthritis [RA] are at increased risk for a fragility fracture [fx]. To help better target those in need of…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology